Skip to main content

Equine

Horses

Description

Butequine™ (phenylbutazone) Paste is the only FDA-approved generic to the original Phenylzone® Paste.

Indications

Butequine is indicated for the relief of inflammatory conditions associated with the musculoskeletal system in horses.

Active Ingredient

Each syringe contains 20 g phenylbutazone.

Dosage and Administration

Each 3 mL marking on the plunger contains 1 g phenylbutazone. 

For oral administration using 1 to 2 g of phenylbutazone per 500 lb. (227 kg) of body weight daily. Do not exceed 4 g daily. 

Refer to the dosage and administration section of the full prescribing information for instructions.

How Packaged

Butequine is available in a 60 mL syringe for oral administration.

Where to Buy

Veterinarians can request Butequine from their Vetoquinol Territory Manager or preferred distributor representative. Butequine is a prescription-only product.

Important Safety Information

IMPORTANT SAFETY INFORMATION: 

Butequine™ (phenylbutazone) Paste is indicated for the relief of inflammatory conditions associated with the musculoskeletal system in horses. CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. WARNING: Do not use in horses intended for human consumption. PRECAUTIONS: Butequine is approved only for oral administration. Stop medication at the first sign of gastrointestinal upset, jaundice, or blood dyscrasia. For full prescribing information, see www.vetoquinolusa.com/butequine-info.

Prescribing Information

Associated Products

NexHA

Equine

NexHA™ (hyaluronate sodium) Injectable Solution

See product